Triple Bridge Acceleration Program “TBAP” aims to support the commercialization of academic research in the medical and life science fields.
Overview
A collaborative program where each participant is tasked with achieving commercialization
The Acceleration Program aims to support the commercialization of academic research in the medical and life science fields.
Awareness Building and Education
Preparing for Commercialization
Project Review
Funding and Resource Support
Academia
(Universities, research institutions, etc.）
- Improve competitiveness as a research institution.
- Enhance resources required for commercialization.
Businesses
(Pharmaceutical companies, medical device manufacturers, etc.)
- Improve access to seed opportunities.
- Mitigate early stage risk.
Investors
(VC, CVC, etc.)
- Gain greater access to investment opportunities.
- Enhance due diligence.
Collaboration
In TBAP, research institutions, strategic companies, and financial investors collaborate to commercialize academic research.
Team
Membership
Corporate
The Acceleration Program outsourced to TBAP
Support / Affiliates
Management Company
TBAP is managed by AIFAM Asset Management in Japan, a wholly owned by AIFAM Group LLC (NY) .
Learn more about AIFAM